Clinical Trial: Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

Brief Summary: Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.

Detailed Summary: Patients receiving clinically indicated echocardiograms and cardiac magnetic resonance imaging at Mayo Clinic will be eligible.
Sponsor: Mayo Clinic

Current Primary Outcome: Left Ventricular Wall Thickness [ Time Frame: approximately 1 week after enrollment ]

All subjects will undergo noncontrast echocardiography, contrast echocardiography and cardiac MRI.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Mayo Clinic

Dates:
Date Received: September 5, 2014
Date Started: October 2014
Date Completion: March 2017
Last Updated: September 26, 2016
Last Verified: September 2016